SNCA

gene product
alpha-synuclein, NACP, PARK1, PARK4, PD1
Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Four alternatively spliced transcripts encoding two different isoforms have been identified for this gene. [provided by RefSeq, Mar 2009]
More gene data

Featured antibodies

Antibodies

 

Filters

Knockdown Initiative

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated in Knockdown Initative
Eligible for validation in KDI
1146 antibodies from 35 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeKDWBELICCIPIHCFC
Novus Biologicals
41 antibodies
Enzo Life Sciences
8 antibodies
Abnova Corporation
36 antibodies
antibodies-online
478 antibodies
Biosensis Pty Ltd
3 antibodies
Cell Signaling Technology, Inc
8 antibodies
Thermo Fisher Scientific Pierce
18 antibodies
GeneTex
18 antibodies
Atlas Antibodies
1 antibody
Proteintech Group
1 antibody
Biorbyt
64 antibodies
R&D Systems
4 antibodies
Acris Antibodies GmbH
90 antibodies
Aviva Systems Biology
25 antibodies
LifeSpan BioSciences, Inc.
99 antibodies